1,496 results on '"Frank, Igor"'
Search Results
2. Comparing Frailty Indices for Risk Stratification in Urologic Oncology: Which Index to Choose?
3. Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy
4. Prevalence, Predictors, and Oncologic Outcomes of Pelvic Organ Involvement in Women Undergoing Radical Cystectomy
5. Cutaneous Ureterostomy Following Radical Cystectomy for Bladder Cancer: A Contemporary Series
6. Perioperative and Oncologic Outcomes Associated with Simultaneous Radical Cystectomy and Nephroureterectomy
7. Effect of Preoperative Multiparametric Magnetic Resonance Imaging on Oncologic and Functional Outcomes Following Radical Prostatectomy
8. The Association of Trainee Involvement in Radical Cystectomy With Perioperative and Oncologic Outcomes
9. Intraoperative Ventilatory Pressures During Robotic Assisted vs Open Radical Cystectomy
10. Role of B7‐H3 in predicting response to neoadjuvant chemotherapy in muscle‐invasive bladder cancer.
11. Evaluation of PD-L1 and B7-H3 expression as a predictor of response to adjuvant chemotherapy in bladder cancer
12. PD17-12 IS THERE A ROLE FOR C-11 PET-CT IN MEN WITH BIOCHEMICAL PROGRESSION OF PROSTATE CANCER AND NEGATIVE PSMA PET-CT?
13. PD34-06 CHANGES IN BODY COMPOSITION FOLLOWING NEOADJUVANT CHEMOTHERAPY FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY
14. PD34-03 INTRAOPERATIVE TRANEXAMIC ACID IN RADICAL CYSTECTOMY: IMPACT ON BLEEDING, THROMBOEMBOLISM, AND CANCER-SPECIFIC SURVIVAL
15. MP12-16 NATIONAL TRENDS IN SAME DAY DISCHARGE FOR RADICAL PROSTATECTOMY: AN EVOLUTION IN PRACTICE PATTERNS
16. MP77-18 PREDICTORS OF PELVIC RECURRENCE AFTER RADICAL CYSTECTOMY: IDENTIFYING THE IDEAL CANDIDATE FOR ADJUVANT RADIATION CLINICAL TRIALS
17. MP07-04 INITIAL EXPERIENCE WITH A FULLY INTEGRATED ARTIFICIAL INTELLIGENCE PLATFORM DURING MINIMALLY INVASIVE SURGERY
18. MP24-15 COMPARING FRAILTY INDICES FOR RISK STRATIFICATION IN UROLOGIC SURGERY: WHICH INDEX TO CHOOSE?
19. MP47-08 IMPACT OF HYPOGONADISM ON RADICAL CYSTECTOMY OUTCOMES
20. Does Ureteral Stent Drainage Prior to Cystectomy Increase the Risk of Subsequent Upper Tract Urothelial Carcinoma and Ureteral Complications?
21. Artificial Intelligence–Based Assessment of Preoperative Body Composition Is Associated With Early Complications After Radical Cystectomy.
22. Cancer Prevalence and Risk Stratification in Adults Presenting With Hematuria: A Population-Based Cohort Study
23. Squamous Cell Carcinoma of the Bladder Is Not Associated With High-risk HPV
24. Treatment Outcomes in Patients With Symptomatic Lymphoceles Following Radical Prostatectomy Depend Upon Size and Presence of Infection
25. Initial Experience with da Vinci Single-port Robot-assisted Radical Prostatectomies
26. Trends in Extended-Duration Venous Thromboembolism Prophylaxis Following Radical Cystectomy
27. IMPACT OF PROSTATE SIZE ON THE OUTCOMES OF RADICAL PROSTATECTOMY
28. VALUE OF B7-H3 EXPRESSION AS A PREDICTOR OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN UROTHELIAL CELL CARCINOMA OF BLADDER
29. Incidence and risk factors for peritoneal carcinomatosis following open radical cystectomy
30. Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes
31. Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
32. A comparison of adult rhabdomyosarcoma and high-grade neuroendocrine carcinoma of the urinary bladder reveals novel PPP1R12A fusions in rhabdomyosarcoma
33. Automated Identification of Key Steps in Robotic-Assisted Radical Prostatectomy Using Artificial Intelligence
34. Navigating Now and Next: Recent Advances and Future Horizons in Robotic Radical Prostatectomy
35. Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation
36. The Association of Aspirin Use with Survival Following Radical Cystectomy
37. The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment
38. The Association Between Sarcopenia and Oncologic Outcomes After Radical Prostatectomy
39. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery
40. Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy
41. Utilization and Outcomes of Radical Cystectomy for High-grade Non–muscle-invasive Bladder Cancer in Elderly Patients
42. Adverse Pathology After Neoadjuvant Chemotherapy and Radical Cystectomy: The Role of Adjuvant Chemotherapy
43. Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience
44. A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk disease
45. Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients with Variant Histology Undergoing Radical Cystectomy
46. Relative impact of lymph-node metastasis and seminal vesical invasion on oncologic outcomes following radical prostatectomy
47. Independent Validation of the American Joint Committee on Cancer 8th Edition Prostate Cancer Staging Classification
48. Long-term Follow-up of a Matched Cohort Study Evaluating the Role of Adjuvant Radiotherapy for Organ-confined Prostate Cancer With a Positive Surgical Margin
49. Impact of Radical Prostatectomy on Long-Term Oncologic Outcomes in a Matched Cohort of Men with Pathological Node Positive Prostate Cancer Managed by Castration
50. Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.